39876888|t|Risk Factors of Delirium Following Reconstructive Surgery for Head and Neck Tumors: A Retrospective Clinical Trial.
39876888|a|Background: Patients after head and neck tumor reconstruction surgery frequently require deep sedation and analgesia in the ICU. However, the risk factors for delirium associated with propofol-based sedation remain unclear. Objective: The study aimed to explore the risk factors of delirium of propofol singled or combined sedation. Methods: This retrospective study analyzed ICU patients who underwent head and neck tumor reconstruction surgery. The patients were divided into three groups: propofol (P), propofol + midazolam (PM), and propofol + dexmedetomidine (PD) groups. We utilized univariate and multivariate logistic regression to identify risk factors of delirium. Results: Delirium occurred in 4 (7.02%), 11 (28.21%), and 5 (20.83%) patients in the P, PM and PD groups, respectively. Elevated mean arterial pressure (MAP), increased aspartate aminotransferase (AST) levels, and the combined use of midazolam were determined to be significant risk factors for delirium in this patient cohort. The combined use of midazolam is the strongest predictor of delirium, which can increase the risk of delirium by 3.218 times (95% CI = 1.041-9.950, p = 0.042). Conclusion: Propofol combined with midazolam for sedation in patients after head and neck tumor reconstruction surgery may increase the risk of delirium.
39876888	16	24	Delirium	Disease	MESH:D003693
39876888	62	82	Head and Neck Tumors	Disease	MESH:D006258
39876888	128	136	Patients	Species	9606
39876888	143	162	head and neck tumor	Disease	MESH:D006258
39876888	275	283	delirium	Disease	MESH:D003693
39876888	300	308	propofol	Chemical	MESH:D015742
39876888	398	406	delirium	Disease	MESH:D003693
39876888	410	418	propofol	Chemical	MESH:D015742
39876888	496	504	patients	Species	9606
39876888	519	538	head and neck tumor	Disease	MESH:D006258
39876888	567	575	patients	Species	9606
39876888	608	616	propofol	Chemical	MESH:D015742
39876888	622	630	propofol	Chemical	MESH:D015742
39876888	633	642	midazolam	Chemical	MESH:D008874
39876888	644	646	PM	Chemical	-
39876888	653	661	propofol	Chemical	MESH:D015742
39876888	664	679	dexmedetomidine	Chemical	MESH:D020927
39876888	681	683	PD	Chemical	-
39876888	781	789	delirium	Disease	MESH:D003693
39876888	800	808	Delirium	Disease	MESH:D003693
39876888	860	868	patients	Species	9606
39876888	876	877	P	Disease	MESH:D002972
39876888	879	881	PM	Chemical	-
39876888	886	888	PD	Chemical	-
39876888	1025	1034	midazolam	Chemical	MESH:D008874
39876888	1086	1094	delirium	Disease	MESH:D003693
39876888	1103	1110	patient	Species	9606
39876888	1139	1148	midazolam	Chemical	MESH:D008874
39876888	1179	1187	delirium	Disease	MESH:D003693
39876888	1220	1228	delirium	Disease	MESH:D003693
39876888	1291	1299	Propofol	Chemical	MESH:D015742
39876888	1314	1323	midazolam	Chemical	MESH:D008874
39876888	1340	1348	patients	Species	9606
39876888	1355	1374	head and neck tumor	Disease	MESH:D006258
39876888	1423	1431	delirium	Disease	MESH:D003693
39876888	Positive_Correlation	MESH:D008874	MESH:D003693
39876888	Negative_Correlation	MESH:D015742	MESH:D006258
39876888	Negative_Correlation	MESH:D008874	MESH:D006258
39876888	Cotreatment	MESH:D008874	MESH:D015742
39876888	Positive_Correlation	MESH:D015742	MESH:D003693
39876888	Cotreatment	MESH:D015742	MESH:D020927

